Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
MD Anderson
mi
from
Houston, TX
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
MD Anderson
mi
from
Houston, TX
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic health system
mi
from
Rochester, MN
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic health system
mi
from
Rochester, MN
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Hospital
mi
from
Phoenix, AZ
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Loma Linda Cancer Center
mi
from
Loma Linda, CA
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Loma Linda Cancer Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Penn State College of Medicine
mi
from
Hershey, PA
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Penn State College of Medicine
mi
from
Hershey, PA
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University Hospitals, Inc
mi
from
Philadelphia, PA
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University Hospitals, Inc
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center (Albert Einstein)
mi
from
Bronx, NY
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center (Albert Einstein)
mi
from
Bronx, NY
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Loyola University Medical Center, Department of Urology
mi
from
Maywood, IL
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center, Department of Urology
mi
from
Maywood, IL
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Seattle Cancer Care Alliance / University of Washington
mi
from
Seattle, WA
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Seattle Cancer Care Alliance / University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Urology Center Las Vegas
mi
from
Las Vegas, NV
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Urology Center Las Vegas
mi
from
Las Vegas, NV
Click here to add this to my saved trials
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated:  12/31/1969
Hasharon Hospital (Rabin Medical Center)
mi
from
Petah Tikva,
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel™ on Ablation of Upper Urinary Tract Urothelial Carcinoma
Status: Enrolling
Updated: 12/31/1969
Hasharon Hospital (Rabin Medical Center)
mi
from
Petah Tikva,
Click here to add this to my saved trials
Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL
A Phase 1, Open-label Study of SNX‑5422 Added to Ibrutinib in Chronic Lymphocytic Leukemia Subjects With Residual Disease
Status: Enrolling
Updated:  12/31/1969
Wexner Medical Center at the Ohio State University
mi
from
Columbus, OH
Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL
A Phase 1, Open-label Study of SNX‑5422 Added to Ibrutinib in Chronic Lymphocytic Leukemia Subjects With Residual Disease
Status: Enrolling
Updated: 12/31/1969
Wexner Medical Center at the Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL
A Phase 1, Open-label Study of SNX‑5422 Added to Ibrutinib in Chronic Lymphocytic Leukemia Subjects With Residual Disease
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Efficacy and Safety of SNX-5422 Added to an Established Dose of Ibrutinib in CLL
A Phase 1, Open-label Study of SNX‑5422 Added to Ibrutinib in Chronic Lymphocytic Leukemia Subjects With Residual Disease
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer
Consolidative Ipilimumab and Nivolumab With Thoracic Radiotherapy After Platinum Based Chemotherapy for Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  12/31/1969
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer
Consolidative Ipilimumab and Nivolumab With Thoracic Radiotherapy After Platinum Based Chemotherapy for Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
An Open Label, Non-randomized, Phase I Dose Escalation Study to Characterize Safety, Tolerability, Pharmacokinetics and Maximum Tolerated Dose of BAY1163877 in Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
An Open Label, Non-randomized, Phase I Dose Escalation Study to Characterize Safety, Tolerability, Pharmacokinetics and Maximum Tolerated Dose of BAY1163877 in Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
An Open Label, Non-randomized, Phase I Dose Escalation Study to Characterize Safety, Tolerability, Pharmacokinetics and Maximum Tolerated Dose of BAY1163877 in Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated:  12/31/1969
mi
from
Besancon,
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
An Open Label, Non-randomized, Phase I Dose Escalation Study to Characterize Safety, Tolerability, Pharmacokinetics and Maximum Tolerated Dose of BAY1163877 in Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 12/31/1969
mi
from
Besancon,
Click here to add this to my saved trials
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
An Open Label, Non-randomized, Phase I Dose Escalation Study to Characterize Safety, Tolerability, Pharmacokinetics and Maximum Tolerated Dose of BAY1163877 in Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)
An Open Label, Non-randomized, Phase I Dose Escalation Study to Characterize Safety, Tolerability, Pharmacokinetics and Maximum Tolerated Dose of BAY1163877 in Subjects With Refractory, Locally Advanced or Metastatic Solid Tumors
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
A Phase 1, Two-Cohort, Open-Label, Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Sarah Cannon Research Institute at HealthONE
mi
from
Denver, CO
Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
A Phase 1, Two-Cohort, Open-Label, Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Sarah Cannon Research Institute at HealthONE
mi
from
Denver, CO
Click here to add this to my saved trials
Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
A Phase 1, Two-Cohort, Open-Label, Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Florida Cancer Specialists
mi
from
Sarasota, FL
Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
A Phase 1, Two-Cohort, Open-Label, Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Florida Cancer Specialists
mi
from
Sarasota, FL
Click here to add this to my saved trials
Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
A Phase 1, Two-Cohort, Open-Label, Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer
Status: Enrolling
Updated:  12/31/1969
Sarah Cannon Research Institute
mi
from
Nashville, TN
Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
A Phase 1, Two-Cohort, Open-Label, Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With Locally Recurrent or Metastatic ER+ Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Centers
mi
from
Aurora, CO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Centers
mi
from
Aurora, CO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Center
mi
from
Boulder, CO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Center
mi
from
Boulder, CO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Center
mi
from
Colorado Springs, CO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Center
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Centers
mi
from
Denver, CO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Centers
mi
from
Denver, CO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Center
mi
from
Lakewood, CO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Center
mi
from
Lakewood, CO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Centers
mi
from
Littleton, CO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Centers
mi
from
Littleton, CO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Centers
mi
from
Lone Tree, CO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Centers
mi
from
Lone Tree, CO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Centers
mi
from
Longmont, CO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Centers
mi
from
Longmont, CO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Centers
mi
from
Parker, CO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Centers
mi
from
Parker, CO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Center
mi
from
Pueblo, CO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Center
mi
from
Pueblo, CO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Cancer Centers
mi
from
Thornton, CO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Cancer Centers
mi
from
Thornton, CO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
University of Miami Sylvester at Deerfield Beach
mi
from
Deerfield Beach, FL
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
University of Miami Sylvester at Deerfield Beach
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
University of Miami Sylvester at Hollywood
mi
from
Hollywood, FL
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
University of Miami Sylvester at Hollywood
mi
from
Hollywood, FL
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
University of Miami Sylvester at Kendall
mi
from
Kendall, FL
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
University of Miami Sylvester at Kendall
mi
from
Kendall, FL
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
University of Miami-Sylvester at Plantation
mi
from
Plantation, FL
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
University of Miami-Sylvester at Plantation
mi
from
Plantation, FL
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Baptist Health Lexington
mi
from
Lexington, KY
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Baptist Health Lexington
mi
from
Lexington, KY
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Baptist Health Louisville
mi
from
Louisville, KY
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Baptist Health Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Baptist Health Paducah
mi
from
Paducah, KY
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Baptist Health Paducah
mi
from
Paducah, KY
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Mercy Research - Springfield
mi
from
Springfield, MO
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Mercy Research - Springfield
mi
from
Springfield, MO
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Northwest Cancer Specialists dba Compass Oncology
mi
from
Portland, OR
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Northwest Cancer Specialists dba Compass Oncology
mi
from
Portland, OR
Click here to add this to my saved trials
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated:  12/31/1969
Northwest Cancer Specialists, P.C. dba Compass Oncology
mi
from
Tualatin, OR
The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Status: Enrolling
Updated: 12/31/1969
Northwest Cancer Specialists, P.C. dba Compass Oncology
mi
from
Tualatin, OR
Click here to add this to my saved trials